Acorda Therapeutics reported $9K in Ordinary Share Capital for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US $ 0.02M 0M
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
Alexion Pharmaceuticals ALXN:US $ 0M 0M
ALKERMES ALKS:US $ 1.65M 0.01M
Amgen AMGN:US $ 31877M 71M
Anika Therapeutics ANIK:US $ 0.14M 0M
Aptinyx Inc APTX:US $ 677K 8K
Arrowhead Research ARWR:US $ 197K 1000
Biogen BIIB:US $ 0.1M 0M
Biomarin Pharmaceutical BMRN:US $ 0.18M 0M
Cara Therapeutics CARA:US $ 50K 0
Cytokinetics CYTK:US $ 0.07M 0M
GlaxoSmithKline GSK:LN 1347M 1M
Gw Pharmaceuticals GWPH:US $ 0.58M 0.01M
Halozyme Therapeutics HALO:US $ 0.14M 0M
Heron Therapeutics HRTX:US $ 1.02M 0.1M
Insmed INSM:US $ 1.15M 119K
Mannkind MNKD:US $ 2.5M 0M
Merck MRK:GR € 168M 0M
Moderna Inc MRNA:US 0 0
Neurocrine Biosciences NBIX:US $ 0.1M 0M
Novartis NOVN:VX SF 913M 0M
Teva Pharmaceutical TEVA:IT 57M 0
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
Vertex Pharmaceuticals VRTX:US $ 2.59M 0M